MAPT and supranuclear palsy, progressive, 1: First-generation tau tracers such as flortaucipir showed good correspondence between in vivo imaging and postmortem PSP and CBD evaluation and second-generation tau PET tracers such as [18F]PI-2620 demonstrated more specificity for 4R-tauopathies3,12.